STOCK TITAN

ReWalk Robotics Ltd. - $RWLK STOCK NEWS

Welcome to our dedicated page for ReWalk Robotics Ltd. news (Ticker: $RWLK), a resource for investors and traders seeking the latest updates and insights on ReWalk Robotics Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ReWalk Robotics Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ReWalk Robotics Ltd.'s position in the market.

Rhea-AI Summary
ReWalk Robotics expresses gratitude to Yohanan Engelhardt for his contributions as a director, but he will no longer serve on the Board. Engelhardt served as chairman of the audit committee for over five years with exemplary performance. ReWalk acknowledges his significant contributions to financial governance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.59%
Tags
none
-
Rhea-AI Summary
ReWalk Robotics CEO to present at H.C. Wainwright conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
conferences
-
Rhea-AI Summary
ReWalk Robotics announces reduction in director seats and resignation of Yasushi Ichiki from the Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
management
Rhea-AI Summary
ReWalk Robotics has announced the completion of its acquisition of AlterG, a leading provider of Anti-Gravity systems for rehabilitation. The purchase price was approximately $19 million in cash, with potential earnout payments based on AlterG's revenue growth. AlterG's systems use NASA-derived technology to reduce the effects of gravity and improve mobility outcomes. Charles Remsberg, former CEO of AlterG, has been appointed as Chief Sales Officer of ReWalk.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. announces financial results for Q2 2023, with total revenue of $1.3 million, a decrease from the previous year. Gross margin was 43.1%, operating expenses were $5.7 million, and net loss was $4.6 million. The pending acquisition of AlterG is expected to contribute to ReWalk's financial results starting in Q3 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
-
Rhea-AI Summary
ReWalk Robotics acquires AlterG, expects revenue growth and improved operating margin. Cash purchase price of $19 million. AlterG generated $20 million in revenue in 2022 with positive operating profit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
conferences earnings
-
Rhea-AI Summary
ReWalk Robotics announced that two members of the Board of Directors, Arik Dan and Wayne Weisman, will not seek re-election. This will reduce the size of the Board from ten to eight directors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary
ReWalk Robotics CEO to Present at Emerging Growth Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
conferences acquisition
Rhea-AI Summary
ReWalk Robotics announces conference call to discuss the proposal to include personal exoskeletons in the Medicare benefit category for braces.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.29%
Tags
conferences
ReWalk Robotics Ltd.

Nasdaq:RWLK

RWLK Rankings

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the